“We’re thrilled to join the CATALIS Network in its efforts to accelerate Quebec’s clinical research footprint and bring innovative therapies to patients, faster. Patients living with rare diseases face an incredibly long diagnostic journey with limited or no treatment options available to them. Through the FAST TRACK program, we can significantly decrease the time it takes to launch and execute a clinical trial and ultimately bring new innovations and hope to patients and their caregivers.”

- Karen Heim, VP General Manager, Alexion Pharma Canada Corp.

“Lilly is honored to join CATALIS Quebec, epanding clinical trial opportunities to patients and healthcare providers in Quebec. With this new partnership, we’re hopeful that we can simplify the approach to starting clinical trials and advance timelines with academic institutions in Quebec to increase opportunities for patients in the province to experience new molecules currently under research.”

- Dr. Sandy Henderson, Vice President, Medical Affairs Eli Lilly Canada
 

“Novo Nordisk Canada is very pleased to be joining the CATALIS Network. We have an ambitious clinical program focused on delivering innovative treatment solutions to benefit patients and improve health outcomes for Canadians living with serious chronic diseases. We believe this partnership will enable us to accelerate the start of clinical trials, as well as increase patient recruitment and referrals in Quebec.”

- Vince Lamanna, Senior Vice President & President, Novo Nordisk Canada Inc.

“Asthma Canada is proud to partner with Clinical Trials Quebec and CATALIS Quebec. It’s imperative to us that people living with asthma in Quebec and across Canada are aware of clinical trial opportunities, and this partnership will help connect more patients to these opportunities. Equally vital is enhancing knowledge and sharing evidence-based information that helps patients and caregivers make informed choices about clinical trial participation and treatment options. We are also excited about the advancements in asthma treatment that will be impacted by clinical trials for the benefit of today’s patients and those of future generations as we continue to work towards our vision of a future without asthma.”

- Jeffrey Beach, President & CEO, Asthma Canada

“Over the past eight years, treatment options for kidney cancer have increased and survival rates for kidney cancer patients have improved - thanks to clinical trials. At Kidney Cancer Canada, we encourage patients to ask about clinical trials and want to provide them with the tools to facilitate that conversation with their oncologist. We are excited to partner with CATALIS, whose mission is to optimise the clinical research environment by accelerating, facilitating, and increasing the number of clinical trials in Quebec. They have developed a patient-centric tool that allows patients to search for trials and helps them along the way. We are strong advocates of shared decision-making, and our partnership with CATALIS is another step in helping our Quebec community start conversations with their doctors about their treatment options.”

- Christine Collins, Executive Director, Kidney Cancer Canada

“The Research and Teaching Unit of the Chaudière-Appalaches CISSS is delighted to be partnering with the CATALIS Network. We are proud to have contributed, through the FAST TRACK Evaluation Service, to ensuring that celiac patients in our region have rapid access to this promising treatment and can participate in its development. This success is due in no small part to the effective collaboration between Dr. Samson's research team, the members of the CATALIS team, the Research Access Point team, the Research Ethics Committee and the relevant departments and services of the institution.”

- Chantal Pilote, Director of Research and University Teaching and Spokesperson, Chaudière-Appalaches CISSS

With a Master’s degree in Microbiology and Immunology and a PMP certification, Stéphanie has 16 years of experience in clinical research. Driven by a passion for project management, her expertise ranges from process improvement and effective problem solving to transparent and engaging communication.

Stéphanie has held coordination, quality assurance and project management positions at several Contract Research Organizations (CRO) and at the Research Institute of the McGill University Health Centre (RI-MUHC).